ARCHIVES

New Therapeutic Modalities In Testing For Patients With Carcinoid Syndrome

This article is from The Cancer Letter archive.

Vol. 26 No. 11 | November 28, 2003

Download PDF Visit The Full Archive

Related Articles

Caris Life Sciences Lays Off Estimated 20 Percent of Staff

October 24, 2014

DCT Board Questions Funding, Direction Of IL-2/LAK Trials

March 3, 1989

CCOP Q&A, List Of Research Bases

September 10, 1982

USC Opts for Its own IL-2 Protocol, Shuns NCI Trial

May 8, 1987

ASCO Hit On Two Sides; AACR Split Criticized

June 26, 1992

City of Hope CEO Michael Friedman: Cancer Centers Must Adapt; “Not Losing Sleep” Over Sequestration

April 5, 2013